Blume Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2K | Buy |
220
+56
| +34% | +$3.87K | ﹤0.01% | 255 |
|
|
2025
Q1 | $11.4K | Buy |
164
+89
| +119% | +$6.18K | ﹤0.01% | 260 |
|
|
2024
Q4 | $6.45K | Sell |
75
-51
| -40% | -$4.39K | ﹤0.01% | 278 |
|
|
2024
Q3 | $15K | Buy |
126
+26
| +26% | +$3.1K | ﹤0.01% | 251 |
|
|
2024
Q2 | $14.3K | Sell |
100
-35
| -26% | -$5K | ﹤0.01% | 233 |
|
|
2024
Q1 | $17.3K | Sell |
135
-65
| -33% | -$8.35K | ﹤0.01% | 221 |
|
|
2023
Q4 | $20.7K | Hold |
200
| – | – | 0.01% | 215 |
|
|
2023
Q3 | $18.2K | Hold |
200
| – | – | 0.01% | 217 |
|
|
2023
Q2 | $16.2K | Buy |
+200
| New | +$16.2K | ﹤0.01% | 222 |
|
|
2016
Q4 | – | Sell |
-458
| Closed | -$10K | – | 207 |
|
|
2016
Q3 | $10K | Hold |
458
| – | – | 0.01% | 154 |
|
|
2016
Q2 | $12K | Buy |
+458
| New | +$12K | 0.01% | 165 |
|